Literature DB >> 12666195

Expression of mouse Tbx22 supports its role in palatogenesis and glossogenesis.

Alexander Herr1, Dominique Meunier, Ines Müller, Andreas Rump, Reinald Fundele, H-Hilger Ropers, Ulrike A Nuber.   

Abstract

TBX22 belongs to the T-box family of transcription factors and was originally found in an in silico approach designed to identify new genes on the human Xq12-q21 region. Mutations in TBX22 have been reported in families with X-linked cleft palate and ankyloglossia (CPX), but the underlying pathogenetic mechanism remained unknown. We have identified mouse Tbx22 and analyzed its expression during embryogenesis by reverse transcriptase-polymerase chain reaction and in situ hybridization. In mouse embryos, it is expressed in distinct areas of the head, namely the mesenchyme of the inferior nasal septum, the posterior palatal shelf before fusion, the attachment of the tongue, and mesenchymal cells surrounding the eye anlage. The localization in the tongue frenulum perfectly correlates with the ankyloglossia phenotype in CPX. Furthermore, we identified positionally conserved binding sites for transcription factors, two of which have been implicated previously in palatogenesis (MSX1, PRX2). Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12666195     DOI: 10.1002/dvdy.10260

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  14 in total

Review 1.  Orofacial clefting: recent insights into a complex trait.

Authors:  Astanand Jugessur; Jeffrey C Murray
Journal:  Curr Opin Genet Dev       Date:  2005-06       Impact factor: 5.578

2.  Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension.

Authors:  Hiroki Morita; Sabine Mazerbourg; Donna M Bouley; Ching-Wei Luo; Kazuhiro Kawamura; Yoshimitsu Kuwabara; Helene Baribault; Hui Tian; Aaron J W Hsueh
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

3.  Ephrin-B1 forward signaling regulates craniofacial morphogenesis by controlling cell proliferation across Eph-ephrin boundaries.

Authors:  Jeffrey O Bush; Philippe Soriano
Journal:  Genes Dev       Date:  2010-09-15       Impact factor: 11.361

Review 4.  Regional regulation of palatal growth and patterning along the anterior-posterior axis in mice.

Authors:  Sylvia A Hilliard; Ling Yu; Shuping Gu; Zunyi Zhang; Yi Ping Chen
Journal:  J Anat       Date:  2005-11       Impact factor: 2.610

5.  Patterning of palatal rugae through sequential addition reveals an anterior/posterior boundary in palatal development.

Authors:  Sophie Pantalacci; Jan Prochazka; Arnaud Martin; Michaela Rothova; Anne Lambert; Laure Bernard; Cyril Charles; Laurent Viriot; Renata Peterkova; Vincent Laudet
Journal:  BMC Dev Biol       Date:  2008-12-16       Impact factor: 1.978

6.  Is the vertebrate head segmented?-evolutionary and developmental considerations.

Authors:  Shigeru Kuratani
Journal:  Integr Comp Biol       Date:  2008-04-17       Impact factor: 3.326

7.  The Mn1 transcription factor acts upstream of Tbx22 and preferentially regulates posterior palate growth in mice.

Authors:  Wenjin Liu; Yu Lan; Erwin Pauws; Magda A Meester-Smoor; Philip Stanier; Ellen C Zwarthoff; Rulang Jiang
Journal:  Development       Date:  2008-10-23       Impact factor: 6.868

8.  A dosage-dependent role for Spry2 in growth and patterning during palate development.

Authors:  Ian C Welsh; Aaron Hagge-Greenberg; Timothy P O'Brien
Journal:  Mech Dev       Date:  2007-07-10       Impact factor: 1.882

9.  Mice with an anterior cleft of the palate survive neonatal lethality.

Authors:  Shuping Gu; Na Wei; Xueyan Yu; Yiping Jiang; Jian Fei; YiPing Chen
Journal:  Dev Dyn       Date:  2008-05       Impact factor: 3.780

10.  Alternative splicing, phylogenetic analysis, and craniofacial expression of zebrafish tbx22.

Authors:  P A Jezewski; P-K Fang; T L Payne-Ferreira; P C Yelick
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.